TY - JOUR
T1 - Utility of cerebrospinal fluid cytology in newly diagnosed childhood ependymoma
AU - Moreno, Lucas
AU - Pollack, Ian F.
AU - Duffner, Patricia K.
AU - Geyer, J. Russell
AU - Grill, Jacques
AU - Massimino, Maura
AU - Finlay, Jonathan L.
AU - Zacharoulis, Stergios
PY - 2010/8/1
Y1 - 2010/8/1
N2 - The role of cytology of cerebrospinal fluid (CSF) has not been established in pediatric ependymoma. Thirty-two children with metastatic ependymoma were analyzed: 11 patients had only positive CSF cytology, 6 had only positive magnetic resonance imaging (MRI) findings, and 15 had both CSF cytology and MRI positive. Twenty-two patients relapsed. Five-year event-free survival was 27.3% ± 13.4% for children with only CSF positive (Ml) versus 26.1% ± 10.2% for patients with positive spine MRI positive (with or without CSF positive, M3) (P = 0.87). In conclusion, 34% of the patients with metastatic ependymoma were identified based on CSF cytology only and their outcome was comparable to patients with macroscopic disease. CSF cytology is a useful tool to stage newly diagnosed patients with ependymoma.
AB - The role of cytology of cerebrospinal fluid (CSF) has not been established in pediatric ependymoma. Thirty-two children with metastatic ependymoma were analyzed: 11 patients had only positive CSF cytology, 6 had only positive magnetic resonance imaging (MRI) findings, and 15 had both CSF cytology and MRI positive. Twenty-two patients relapsed. Five-year event-free survival was 27.3% ± 13.4% for children with only CSF positive (Ml) versus 26.1% ± 10.2% for patients with positive spine MRI positive (with or without CSF positive, M3) (P = 0.87). In conclusion, 34% of the patients with metastatic ependymoma were identified based on CSF cytology only and their outcome was comparable to patients with macroscopic disease. CSF cytology is a useful tool to stage newly diagnosed patients with ependymoma.
KW - CSF cytology
KW - Metastatic ependymoma
KW - Prognosis
UR - http://www.scopus.com/inward/record.url?scp=77955896907&partnerID=8YFLogxK
U2 - 10.1097/MPH.0b013e3181d7adf5
DO - 10.1097/MPH.0b013e3181d7adf5
M3 - Article
C2 - 20463607
AN - SCOPUS:77955896907
SN - 1077-4114
VL - 32
SP - 515
EP - 518
JO - Journal of Pediatric Hematology/Oncology
JF - Journal of Pediatric Hematology/Oncology
IS - 6
ER -